undamentalytics Newsletter
Sign in

Rafael Holdings, Inc. income statement

In fiscal 2026, Rafael Holdings, Inc. reported revenue of $874,000, down 4.7% on the year before, operating income of −$33.4m (a -3822.5% margin) and net income of −$29.6m, or −$0.58 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Jul 20162017Jul 20172018Jul 20182019Jul 20192020Jul 20202021Jul 20212022Jul 20222023Jul 20232024Jul 20242025Jul 20252026Jul 2026
Revenue66455100111
Cost of revenue—————33—0——
Gross profit—————−2−3—0——
Research and development——11259641324
Selling, general and administrative346991717————
General and administrative———————991410
Operating income10−4−7−8−28−60−15−103−29−33
Interest expense————000—010
Net interest income−0000−0−0—————
Income before tax10−4−5−7−23−140−9−67−33−28
Income tax008−000—−0−3−3−0
Net income10−12−5−11−23−125−2−34−31−30
Diluted EPS$0.06$0.01−$0.92−$0.35−$0.66−$1.49−$6.31−$0.08−$1.45−$1.04−$0.58
Diluted shares (average)———13m16m17m20m24m24m29m51m
EBITDA32−2−5−7−28−60−15−102−29−33

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MNOV vs RFLRFL vs STTKLGVN vs RFL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Rafael Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rafael Holdings, Inc.